Cell line-specific efficacy of thermoradiotherapy in human and canine cancer cells in vitro

PLoS One. 2019 May 15;14(5):e0216744. doi: 10.1371/journal.pone.0216744. eCollection 2019.

Abstract

Objective: Aims were to investigate sensitivity of various human and canine cancer cell lines to hyperthermia and the influence of particular treatment conditions, and to analyze the DNA-damage response and mode of cell death in cell line radiosensitized by hyperthermia. Additionally, we were interested in the involvement of HSP70 in radiosensitization.

Methods: Radiosensitization by hyperthermia was determined in a panel of human and canine cancer cell lines using clonogenic cell survival assay, as well as levels of heat shock proteins (HSPs) using immunoblotting. The influence of the hyperthermia-radiotherapy time gap, different temperatures and the order of treatments on clonogenicity of hyperthermia-sensitive A549 cells was investigated. Additionally, DNA damage and cell death were assessed by Comet assay and an apoptosis/necrosis assay. Further we induced transient knockdown in A549 cells to test HSP70's involvement in radiosensitization.

Results: Out of eight cell lines tested, only two (A549 and Abrams) showed significant decrease in clonogenic cell survival when pre-treated with hyperthermia at 42°C. Strong induction of HSP70 upon thermoradiotherapy (HT-RT) treatment was found in all cell lines. Transient knockdown of HSP70 in A549 cells did not result in decrease of clonogenic cell survival in response to HT-RT.

Conclusion: Tumor cell-type, temperature and order of treatment play an important role in radiosensitization by hyperthermia. However, hyperthermia has limited potency to radiosensitize canine cancer cells grown in a 2D cell culture setting presented here. DNA damage and apoptosis/necrosis did not increase upon combined treatment and cytosolic levels of HSP70 appear not to play critical role in the radiosensitization of A549 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Animals
  • Cell Death / radiation effects
  • Cell Line, Tumor
  • Cell Survival / radiation effects
  • Combined Modality Therapy
  • DNA Damage
  • Dogs
  • Gene Knockdown Techniques
  • HSP70 Heat-Shock Proteins / antagonists & inhibitors
  • HSP70 Heat-Shock Proteins / genetics
  • HSP70 Heat-Shock Proteins / metabolism
  • Humans
  • Hyperthermia, Induced / methods*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Rad51 Recombinase / metabolism
  • Radiation Tolerance*
  • Tumor Stem Cell Assay

Substances

  • HSP70 Heat-Shock Proteins
  • Rad51 Recombinase

Grants and funding

This work was supported by the Marie-Louise von Muralt Stiftung für Kleintiere, Zurich, Switzerland, to CRB; Swiss National Foundation (grant number 320030_163435 to SS and CRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.